The Netherlands: Europe’s most attractive and innovative biopharmaceutical industry environment

With an unrivalled concentration of biopharmaceutical ecosystems, world-class universities and a long history of strategic partnerships between science, industry and government, the Netherlands is a perfect location for biopharmaceutical innovation in Europe. Many ground-breaking companies have already established themselves in the Netherlands. The EMA will soon follow in their footsteps and relocate to Amsterdam. This confirms once more that the Netherlands is the perfect home for biopharmaceuticalcompanies all around the globe.

Read all about the advantages of setting up your business in the Netherlands in this special bid book for the biopharmaceutical industry. It demonstrates all the reasons why the Netherlands is a top location for pharmaceutical operations for those biopharmaceutical companies that are interested in locating their company in the Netherlands.

Read the bid book by clicking on the cover below:

The following partners have contributed to the development of the bid book: AmCham, Association Innovative Medicines, Health~Holland, HollandBIO, Lygature, Ministry of Economic Affairs and Climate Policy, Netherlands Foreign Investment Agency, PharmInvestHolland, VNO-NCW.

Invest In Holland Network - A powerful team ready to help
The Invest in Holland Network is a collaborative team of the Netherlands Foreign Investment Agency, regional economic development agencies and several large cities. The network works to provide a continuum of free, confidential support services to new foreign investors, as well as existing foreign investors that already have operations in the Netherlands. They connect you to the right partners to assist to assist with everything from recruiting talent to introducing you to powerful public-private partnerships.

The services provided by the Invest in Holland Network are 100% confidential and completely free of charge. Find out more via Invest in Holland.